DuPont Industrial Biosciences (IB; www.biosciences.dupont.com) officially opened the doors of its renovated global business headquarters in Wilmington, Del. This new center of technological innovation, known as Building E353, is part of DuPont’s Experimental Station.
The researchers, business teams and cutting-edge laboratories at the new E353 facility will continue the tradition of innovation and scientific advancement on the historic Experimental Station site, while fostering the next wave of progress in industrial biosciences that results in better and more sustainable products and processes for customers across the globe.
“At this new facility, we have hundreds of people working toward a more sustainable future by innovating biobased solutions that are better, safer and more renewable. These technologies go into products that are used in everyday life,” said William Feehery, president of DuPont Industrial Biosciences. “The redesigned and upgraded laboratories and office spaces are incubators for some of DuPont’s most groundbreaking work.”
The revitalization of Building E353 is part of a more than $200 million investment in the Experimental Station campus, which began in 2016 and encompasses about 50 buildings, with over 2 million square feet of space. The E353 refurbishment focused on modernization, consolidation and advanced capabilities.
“This building and the state-of-the-art research performed by talented and diverse employees builds on DuPont’s legacy of discovery and innovation,” said Marc Doyle, COO of DowDuPont Specialty Products Division. “As we enter our next phase of growth, we are excited that the Specialty Products Division will carry the DuPont name and continue to call Delaware home. The new DuPont will be a premier innovation-driven leader delivering highly specialized products and solutions that transform industries and improve everyday life.”